Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours lymphoid neoplasms. Leuk 367;36:1720–1748. https://doi.org/10.1038/s41375-022-01620-2

Campo E, Jaffe ES, Cook JR et al (2022) The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the clinical advisory committee. Blood 140:1229–1253. https://doi.org/10.1182/BLOOD.2022015851

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sarkozy C, Copie-Bergman C, Damotte D et al (2019) Gray-zone lymphoma between cHL and large B-cell lymphoma. Am J Surg Pathol 43:341–351. https://doi.org/10.1097/PAS.0000000000001198

Article  PubMed  Google Scholar 

Sarkozy C, Chong L, Takata K et al (2020) Gene expression profiling of gray zone lymphoma. Blood Adv 4:2523–2535. https://doi.org/10.1182/BLOODADVANCES.2020001923

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sarkozy C, Hung SS, Chavez EA, et al (2021) Mutational landscape of grey zone lymphoma mutational landscape of grey zone lymphoma centre for lymphoid cancer, British Columbia Cancer, Vancouver, BC, Canada. 2 INSERM Unité Mixte de Recherche ( UMR ) -S1052 , Centre National de la Recherche UMR 5

Maracaja DLV, Puthenpura V, Pels SG et al (2020) EBV-Positive primary large B-cell lymphoma: the role of immunohistochemistry and XPO1 in the diagnosis of mediastinal lymphomas. Appl Immunohistochem Mol Morphol 28:725–730. https://doi.org/10.1097/PAI.0000000000000820

Article  CAS  PubMed  Google Scholar 

Duns G, Viganò E, Ennishi D et al (2021) Characterization of DLBCL with a PMBL gene expression signature. Blood 138:136–148. https://doi.org/10.1182/BLOOD.2020007683

Article  CAS  PubMed  Google Scholar 

Gong QX, Wang Z, Liu C et al (2018) CD30 expression and its correlation with MYC and BCL2 in de novo diffuse large B-cell lymphoma. J Clin Pathol 71:795–801. https://doi.org/10.1136/jclinpath-2018-205039

Article  CAS  PubMed  Google Scholar 

Bledsoe JR, Redd RA, Hasserjian RP et al (2016) The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome. Am J Hematol 91:E436–E441. https://doi.org/10.1002/ajh.24485

Article  CAS  PubMed  Google Scholar 

Calaminici M, Piper K, Lee AM, Norton AJ (2004) CD23 expression in mediastinal large B-cell lymphomas. Histopathology 45:619–624. https://doi.org/10.1111/j.1365-2559.2004.01969.x

Article  CAS  PubMed  Google Scholar 

Menter T, Bodmer-Haecki A, Dirnhofer S, Tzankov A (2016) Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas. Hum Pathol 54:17–24. https://doi.org/10.1016/j.humpath.2016.03.005

Article  CAS  PubMed  Google Scholar 

Bobée V, Ruminy P, Marchand V et al (2017) Determination of molecular subtypes of diffuse large B-cell lymphoma using a reverse transcriptase multiplex ligation-dependent probe amplification classifier: a CALYM study. J Mol Diagn JMD 19:892–904. https://doi.org/10.1016/J.JMOLDX.2017.07.007

Article  PubMed  Google Scholar 

Aladily TN, Mansour A, Alsughayer A et al (2019) The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma. Ann Diagn Pathol 40:72–76. https://doi.org/10.1016/j.anndiagpath.2019.04.009

Article  PubMed  Google Scholar 

Bourbon E, Maucort-Boulch D, Fontaine J et al (2021) Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified. Blood Adv 5:3227–3239. https://doi.org/10.1182/BLOODADVANCES.2021004515

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mottok A, Hung SS, Chavez EA et al (2019) Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma. Blood 134:802–813. https://doi.org/10.1182/blood.2019001126

Article  CAS  PubMed  Google Scholar 

Frontzek F, Staiger AM, Wullenkord R et al (2023) Molecular profiling of EBV associated diffuse large B-cell lymphoma. Leukemia 37:670–679. https://doi.org/10.1038/S41375-022-01804-W

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gebauer N, Künstner A, Ketzer J et al (2021) Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing. Blood Cancer J 11:102. https://doi.org/10.1038/S41408-021-00493-5

Article  PubMed  PubMed Central  Google Scholar 

Steidl C, Shah SP, Woolcock BW et al (2011) MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 471:377–383. https://doi.org/10.1038/nature09754

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang XN, Yu BH, Yan WH et al (2019) Epstein-Barr virus-positive diffuse large B-cell lymphoma features disrupted antigen capture/presentation and hijacked T-cell suppression. Oncoimmunology 9. https://doi.org/10.1080/2162402X.2019.1683346

Eberle FC, Salaverria I, Steidl C et al (2011) Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations. Mod Pathol 24:1586–1597. https://doi.org/10.1038/modpathol.2011.116

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bednarska K, Chowdhury R, Tobin JWD et al (2024) Epstein-Barr virus-associated lymphomas decoded. Br J Haematol 204:415–433. https://doi.org/10.1111/bjh.19255

Article  CAS  PubMed  Google Scholar 

Gibson SE, Dojcinov S, Dotlic S et al (2023) Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology. Virchows Arch 483:733–749. https://doi.org/10.1007/s00428-023-03550-5

Article  PubMed  PubMed Central  Google Scholar 

Camus V, Stamatoullas A, Mareschal S et al (2016) Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma. Haematologica 101:1094–1101. https://doi.org/10.3324/haematol.2016.145102

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jardin F, Pujals A, Pelletier L et al (2016) Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma. Am J Hematol 91:923–930. https://doi.org/10.1002/ajh.24451

Article  CAS  PubMed  Google Scholar 

Tiacci E, Ladewig E, Schiavoni G et al (2018) Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma. Blood 131:2454–2465. https://doi.org/10.1182/blood-2017-11-814913

Article  CAS  PubMed  PubMed Central  Google Scholar